Wealthspire Advisors, LLC Eli Lilly & CO Transaction History

Wealthspire Advisors, LLC

$7.78 Billion
Q2 2024

A detailed history of Wealthspire Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Wealthspire Advisors, LLC holds 5,712 shares of LLY stock, worth $5.19 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

5,712

Previous 5,999 4.78%

Holding current value

$5.19 Million

Previous $4.67 Million 10.82%

% of portfolio

0.07%

Previous 0.06%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$724.87 - $909.04 $208,037 - $260,894	-287 Reduced 4.78%	5,712 $5.17 Million
Q1 2024 May 06, 2024	SELL	$592.2 - $792.28 $239,841 - $320,873	-405 Reduced 6.32%	5,999 $4.67 Million
Q4 2023 Feb 06, 2024	BUY	$525.19 - $619.13 $236,860 - $279,227	451 Added 7.58%	6,404 $3.73 Million
Q3 2023 Nov 06, 2023	BUY	$434.7 - $599.3 $1.01 Million - $1.39 Million	2,319 Added 63.81%	5,953 $3.2 Million
Q2 2023 Jul 31, 2023	SELL	$350.74 - $468.98 $36,476 - $48,773	-104 Reduced 2.78%	3,634 $1.7 Million
Q1 2023 May 09, 2023	SELL	$310.63 - $364.82 $633,995 - $744,597	-2,041 Reduced 35.32%	3,738 $1.28 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $581,362 - $677,403	1,808 Added 45.53%	5,779 $2.11 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $378,308 - $431,122	1,276 Added 47.35%	3,971 $1.28 Million
Q2 2022 Aug 09, 2022	BUY	$278.73 - $327.27 $184,797 - $216,980	663 Added 32.63%	2,695 $874,000
Q1 2022 May 09, 2022	SELL	$234.69 - $291.66 $843,475 - $1.05 Million	-3,594 Reduced 63.88%	2,032 $582,000
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $185,501 - $230,208	-825 Reduced 12.79%	5,626 $1.55 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $882,189 - $1.09 Million	3,981 Added 161.17%	6,451 $1.49 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $1.72 Million - $2.23 Million	-9,528 Reduced 79.41%	2,470 $567,000
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $451,222 - $584,129	2,746 Added 29.68%	11,998 $2.24 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $326,019 - $431,402	2,499 Added 37.01%	9,252 $1.56 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $266,266 - $307,985	1,821 Added 36.92%	6,753 $1 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $919,197 - $1.11 Million	-6,738 Reduced 57.74%	4,932 $810,000
Q1 2020 May 12, 2020	BUY	$119.05 - $147.35 $1.07 Million - $1.33 Million	9,007 Added 338.23%	11,670 $1.62 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $64,258 - $79,590	601 Added 29.15%	2,663 $350,000
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $220,200 - $239,521	2,062 New	2,062 $231,000
Q1 2019 May 08, 2019	SELL	$111.31 - $131.02 $96,283 - $113,332	-865 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $91,603 - $102,623	865 New	865 $100,000

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthspire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthspire Advisors, LLC with notifications on news.

Account

Wealthspire Advisors, LLC Eli Lilly & CO Transaction History